Escient Pharmaceuticals Revenue and Competitors

Location

#3928

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Escient Pharmaceuticals's estimated annual revenue is currently $4.7M per year.(i)
  • Escient Pharmaceuticals's estimated revenue per employee is $150,000
  • Escient Pharmaceuticals's total funding is $238M.

Employee Data

  • Escient Pharmaceuticals has 31 Employees.(i)
  • Escient Pharmaceuticals grew their employee count by -45% last year.

Escient Pharmaceuticals's People

NameTitleEmail/Phone
1
SVPReveal Email/Phone
2
VP, Finance and AdministrationReveal Email/Phone
3
VP CMCReveal Email/Phone
4
VP, Chemistry Manufacturing and ControlsReveal Email/Phone
5
Associate Director, Clinical SuppliesReveal Email/Phone
6
Director, ChemistryReveal Email/Phone
7
DirectorReveal Email/Phone
8
Associate Director, Translational Biology and Drug DiscoveryReveal Email/Phone
9
Executive Director, Clinical DevelopmentReveal Email/Phone
10
Associate Director, Translational BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Escient Pharmaceuticals?

We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases. Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this regionᅢᄁ¬ツᆲ¬トᄁs life sciences ecosystem and specific expertise in GPCR drug discovery and development. Escient Pharmaceuticals is supported by top-tier life-sciences investors with a proven track record for identifying and supporting successful, next-generation medicines companies.

keywords:N/A

$238M

Total Funding

31

Number of Employees

$4.7M

Revenue (est)

-45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Escient Pharmaceuticals News

2020-10-12 - Escient Raises $77.5M Series B

Photo Courtesy of Escient Pharmaceuticals. San Diego biotech Escient Pharmaceuticals reeled in $77.5 million in its latest funding round. San Diego-based biotech Escient Pharmaceuticals, has announced it has raised a $77... Take 1 minute to subscribe and you'll get this story immediately, plus ...

2020-09-14 - Escient Pharmaceuticals Finds $77.5M In Series B

San Diego-based Escient Pharmaceuticals, which is developing treatments for mast cell-related diseases, said on Monday that it has raised $77.5M in a Series B funding round. According to the company, the funding round was led by Sanofi Ventures and Cowen Healthcare Investments and included new i ...

2018-05-10 - Escient Pharmaceutials Closes $40m in Series A Funding

Escient Pharmaceutials, a San Diego, CA-based biotech company, closed $40m in Series A funding. Backers included The Column Group, 5AM Ventures and Osage University Partners. In conjunction with the funding, JJ Kang, Ph.D., Principal at The Column Group, Andrew J. Schwab, Founder and Managing P ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M31N/AN/A
#2
$3.6M31N/AN/A
#3
$3.6M31N/AN/A
#4
$4.8M3111%N/A
#5
$2.4M31-6%$37M